Literature DB >> 8200271

Gastrointestinal hemorrhage and intestinal ischemia associated with anticardiolipin antibodies.

M S Cappell1, N Mikhail, N Gujral.   

Abstract

Two patients developed unusual causes of severe gastrointestinal hemorrhage associated with anticardiolipin antibodies. One patient bled from small bowel ischemia and mesenteric thrombosis. Another patient bled massively from an ulcer of the descending duodenum which was refractory to standard antiulcer therapy. Ischemia may have contributed to the atypical ulcer presentation in this second patient, which included atypical ulcer location, ulcer refractoriness to standard peptic ulcer therapy, and severe recurrent hemorrhage. In five previously reported cases intestinal infarction associated with anticardiolipin antibodies presented, as it usually presents in patients without anticardiolipin antibodies, as an acute abdomen without acute gastrointestinal bleeding. The current study demonstrates that intestinal ischemia due to thrombosis is in the differential diagnosis of gastrointestinal bleeding in the anticardiolipin antibody syndrome.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8200271     DOI: 10.1007/bf02093805

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  34 in total

Review 1.  The anticardiolipin syndrome.

Authors:  T Danao; E G Camara
Journal:  Am Fam Physician       Date:  1989-01       Impact factor: 3.292

Review 2.  Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.

Authors:  P E Love; S A Santoro
Journal:  Ann Intern Med       Date:  1990-05-01       Impact factor: 25.391

3.  Budd-Chiari syndrome and the lupus anticoagulant.

Authors:  F Roudot-Thoraval; M Gouault-Heilmann; E S Zafrani; J Barge; D Dhumeaux
Journal:  Gastroenterology       Date:  1985-02       Impact factor: 22.682

4.  Thrombotic cutaneous nodules and hepatic vein thrombosis in the anticardiolipin syndrome.

Authors:  J M Farrant; M Judge; R P Thompson
Journal:  Clin Exp Dermatol       Date:  1989-07       Impact factor: 3.470

5.  Occlusion of small hepatic veins associated with systemic lupus erythematosus with the lupus anticoagulant and anti-cardiolipin antibody.

Authors:  H Nakamura; H Uehara; T Okada; H Kambe; Y Kimura; H Ito; E Hayashi; H Yamamoto; S Kishimoto
Journal:  Hepatogastroenterology       Date:  1989-10

6.  Budd-Chiari syndrome in a patient with the lupus anticoagulant.

Authors:  C Pomeroy; R G Knodell; W R Swaim; P Arneson; M L Mahowald
Journal:  Gastroenterology       Date:  1984-01       Impact factor: 22.682

7.  Multiple venous and arterial thromboses associated with the lupus anticoagulant and antibodies to cardiolipin in the absence of SLE.

Authors:  R A Asherson; C G Mackworth-Young; E N Harris; A E Gharavi; G R Hughes
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

8.  Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases.

Authors:  D A Gastineau; F J Kazmier; W L Nichols; E J Bowie
Journal:  Am J Hematol       Date:  1985-07       Impact factor: 10.047

9.  Pancreatitis related to antiphospholipid antibody syndrome in a patient with systemic lupus erythematosus.

Authors:  C R Wang; H C Hsieh; G L Lee; C Y Chuang; C Y Chen
Journal:  J Rheumatol       Date:  1992-07       Impact factor: 4.666

10.  Splenic infarction associated with anticardiolipin antibodies in a patient with acquired immunodeficiency syndrome.

Authors:  M S Cappell; T Simon; M Tiku
Journal:  Dig Dis Sci       Date:  1993-06       Impact factor: 3.199

View more
  9 in total

1.  Mesenteric venous thrombosis causing jejunal stricture: secondary to hypercoagulable states and primary portal hypertension.

Authors:  S Chandra; U Dutta; R Das; K Vaiphei; B Nagi; K Singh
Journal:  Dig Dis Sci       Date:  2002-09       Impact factor: 3.199

2.  Catastrophic antiphospholipid syndrome masquerading as ischaemic colitis.

Authors:  Jan Steffen Jürgensen; Ralf Kettritz; Wolfgang Schneider; Herbert Koop; Thorsten Sven Hildebrand; Ulrich Frei; Kai-Uwe Eckardt
Journal:  Rheumatol Int       Date:  2003-03-29       Impact factor: 2.631

3.  Segmental small bowel necrosis associated with antiphospholipid syndrome: a case report.

Authors:  Qun-Ying Wang; Xiao-Hua Ye; Jin Ding; Xiao-Kang Wu
Journal:  World J Gastroenterol       Date:  2015-04-07       Impact factor: 5.742

4.  Gastrointestinal bleeding and intestinal ischemia associated with anticardiolipin antibodies.

Authors:  A A Mihas
Journal:  Dig Dis Sci       Date:  1995-05       Impact factor: 3.199

Review 5.  Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview.

Authors:  Penka A Atanassova
Journal:  Yonsei Med J       Date:  2007-12-31       Impact factor: 2.759

6.  Postpartum spontaneous colonic perforation due to antiphospholipid syndrome.

Authors:  Kamran Ahmed; Amir Darakhshan; Eleanor Au; Munther A Khamashta; Iraklis E Katsoulis
Journal:  World J Gastroenterol       Date:  2009-01-28       Impact factor: 5.742

7.  Massive gangrene of the stomach due to primary antiphospholipid syndrome: report of two cases.

Authors:  Vivek Srivastava; Somprakas Basu; Mumtaz Ansari; Saroj Gupta; Anand Kumar
Journal:  Surg Today       Date:  2010-01-28       Impact factor: 2.549

8.  The significance of gastric and duodenal histological ischemia reported on endoscopic biopsy.

Authors:  J Herman; D Chavalitdhamrong; D M Jensen; G Cortina; A Manuyakorn; R Jutabha
Journal:  Endoscopy       Date:  2011-02-28       Impact factor: 10.093

Review 9.  Unusual manifestations of the antiphospholipid syndrome.

Authors:  Ronald A Asherson; Ricard Cervera
Journal:  Clin Rev Allergy Immunol       Date:  2003-08       Impact factor: 8.667

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.